The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples